{"id": "8Bm3YUwAAAAJ", "citedby": 4244, "citedby5y": 3433, "hindex": 31, "hindex5y": 30, "i10index": 42, "i10index5y": 42, "coauthors": [], "name": "Chad V. Pecot", "affiliation": "Associate Professor, University of North Carolina", "interests": ["Cancer Biology", "Metastasis", "RNA Interference"], "cites_per_year": {"2011": 37, "2012": 128, "2013": 221, "2014": 374, "2015": 518, "2016": 620, "2017": 677, "2018": 650, "2019": 663, "2020": 298}, "publications": [{"bib": {"title": "RNA interference in the clinic: challenges and future directions", "year": "2011"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:u5HHmVD_uO8C", "citedby": "726"}, {"bib": {"title": "Paraneoplastic thrombocytosis in ovarian cancer", "year": "2012"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:u-x6o8ySG0sC", "citedby": "506"}, {"bib": {"title": "Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer", "year": "2013"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:9yKSN-GCB0IC", "citedby": "327"}, {"bib": {"title": "Tumour angiogenesis regulation by the miR-200 family", "year": "2013"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:IjCSPb-OGe4C", "citedby": "287"}, {"bib": {"title": "Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles", "year": "2011"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:d1gkVwhDpl0C", "citedby": "188"}, {"bib": {"title": "Hematogenous metastasis of ovarian cancer: rethinking mode of spread", "year": "2014"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:qxL8FJ1GzNcC", "citedby": "187"}, {"bib": {"title": "A novel platform for detection of CK+ and CK\u2212 CTCs", "year": "2011"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:2osOgNQ5qMEC", "citedby": "161"}, {"bib": {"title": "Systematic identification of molecular subtype-selective vulnerabilities in non-small-cell lung cancer", "year": "2013"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:YsMSGLbcyi4C", "citedby": "145"}, {"bib": {"title": "Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER", "year": "2014"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:qUcmZB5y_30C", "citedby": "140"}, {"bib": {"title": "Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment", "year": "2013"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:W7OEmFMy1HYC", "citedby": "124"}, {"bib": {"title": "Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression", "year": "2014"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:hC7cP41nSMkC", "citedby": "116"}, {"bib": {"title": "Role of focal adhesion kinase in regulating YB\u20131\u2013mediated paclitaxel resistance in ovarian cancer", "year": "2013"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:Tyk-4Ss8FVUC", "citedby": "95"}, {"bib": {"title": "Mediating passive tumor accumulation through particle size, tumor type, and location", "year": "2017"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:70eg2SAEIzsC", "citedby": "84"}, {"bib": {"title": "Augmentation of response to chemotherapy by microRNA-506 through regulation of RAD51 in serous ovarian cancers", "year": "2015"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:iH-uZ7U-co4C", "citedby": "80"}, {"bib": {"title": "A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer", "year": "2016"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:O3NaXMp0MMsC", "citedby": "74"}, {"bib": {"title": "2\u2032-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity", "year": "2014"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:3fE2CSJIrl8C", "citedby": "72"}, {"bib": {"title": "Combining anti-miR-155 with chemotherapy for the treatment of lung cancers", "year": "2017"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:lSLTfruPkqcC", "citedby": "68"}, {"bib": {"title": "Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression", "year": "2016"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:k_IJM867U9cC", "citedby": "61"}, {"bib": {"title": "Added value of a serum proteomic signature in the diagnostic evaluation of lung nodules", "year": "2012"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:qjMakFHDy7sC", "citedby": "58"}, {"bib": {"title": "Differential platelet levels affect response to taxane-based therapy in ovarian cancer", "year": "2015"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:_Qo2XoVZTnwC", "citedby": "54"}, {"bib": {"title": "FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal", "year": "2016"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:ns9cj8rnVeAC", "citedby": "51"}, {"bib": {"title": "Erythropoietin stimulates tumor growth via EphB4", "year": "2015"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:bEWYMUwI8FkC", "citedby": "51"}, {"bib": {"title": "Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancer", "year": "2016"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:j3f4tGmQtD8C", "citedby": "49"}, {"bib": {"title": "Therapeutic silencing of KRAS using systemically delivered siRNAs", "year": "2014"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:ZeXyd9-uunAC", "citedby": "47"}, {"bib": {"title": "Notch3 pathway alterations in ovarian cancer", "year": "2014"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:4TOpqqG69KYC", "citedby": "44"}, {"bib": {"title": "Metronomic activity of CD44-targeted hyaluronic acid-paclitaxel in ovarian carcinoma", "year": "2012"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:UeHWp8X0CEIC", "citedby": "39"}, {"bib": {"title": "Antagonism of tumoral prolactin receptor promotes autophagy-related cell death", "year": "2014"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:_kc_bZDykSQC", "citedby": "37"}, {"bib": {"title": "miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer", "year": "2016"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:GnPB-g6toBAC", "citedby": "36"}, {"bib": {"title": "Copy number gain of hsa-miR-569 at 3q26. 2 leads to loss of TP53INP1 and aggressiveness of epithelial cancers", "year": "2014"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:4JMBOYKVnBMC", "citedby": "35"}, {"bib": {"title": "Role of Increased n-acetylaspartate Levels in Cancer", "year": "2016"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:blknAaTinKkC", "citedby": "33"}, {"bib": {"title": "Nature communications", "year": "2011"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:J_g5lzvAfSwC", "citedby": "33"}, {"bib": {"title": "KRAS suppression-induced degradation of MYC is antagonized by a MEK5-ERK5 compensatory mechanism", "year": "2018"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:fPk4N6BV_jEC", "citedby": "30"}, {"bib": {"title": "Targeting SRC and tubulin in mucinous ovarian carcinoma", "year": "2013"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:5nxA0vEk-isC", "citedby": "26"}, {"bib": {"title": "Association of STK11/LKB1 genomic alterations with lack of benefit from the addition of pembrolizumab to platinum doublet chemotherapy in non-squamous non-small cell lung cancer.", "year": "2019"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:EUQCXRtRnyEC", "citedby": "19"}, {"bib": {"title": "Factor XIIIA\u2014expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking", "year": "2018"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:3s1wT3WcHBgC", "citedby": "19"}, {"bib": {"title": "Germline mutation of T790M and dual/multiple EGFR mutations in patients with lung adenocarcinoma", "year": "2016"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:maZDTaKrznsC", "citedby": "19"}, {"bib": {"title": "Cross-talk between EphA2 and BRaf/CRaf is a key determinant of response to Dasatinib", "year": "2014"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:ULOm3_A8WrAC", "citedby": "18"}, {"bib": {"title": "Endothelial miR-30c suppresses tumor growth via inhibition of TGF-\u03b2\u2013induced Serpine1", "year": "2019"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:f2IySw72cVMC", "citedby": "14"}, {"bib": {"title": "Targeting accessories to the crime: nanoparticle nucleic acid delivery to the tumor microenvironment", "year": "2018"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:SeFeTyx0c_EC", "citedby": "14"}, {"bib": {"title": "Suppression of myeloid cell arginase activity leads to therapeutic response in a NSCLC mouse model by activating anti-tumor immunity", "year": "2019"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:a0OBvERweLwC", "citedby": "12"}, {"bib": {"title": "Cancer\u2019s got nerve: Schwann cells drive perineural invasion", "year": "2016"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:BqipwSGYUEgC", "citedby": "12"}, {"bib": {"title": "A genome\u2010scale screen reveals context\u2010dependent ovarian cancer sensitivity to miRNA overexpression", "year": "2015"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:isC4tDSrTZIC", "citedby": "11"}, {"bib": {"title": "Enhancing anti-angiogenic therapy by blocking focal adhesion kinase", "year": "2011"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:Y0pCki6q_DkC", "citedby": "8"}, {"bib": {"title": "Quaking orchestrates a post-transcriptional regulatory network of endothelial cell cycle progression critical to angiogenesis and metastasis", "year": "2019"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:bFI3QPDXJZMC", "citedby": "5"}, {"bib": {"title": "Phase II study of stereotactic radiosurgery for the treatment of patients with oligoprogression on erlotinib", "year": "2019"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:D03iK_w7-QYC", "citedby": "3"}, {"bib": {"title": "A survey of microRNA single nucleotide polymorphisms identifies novel breast cancer susceptibility loci in a case-control, population-based study of African-American women", "year": "2018"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:rO6llkc54NcC", "citedby": "3"}, {"bib": {"title": "Nab\u2010paclitaxel in older patients with non\u2013small cell lung cancer who have developed disease progression after platinum\u2010based doublet chemotherapy", "year": "2020"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:1sJd4Hv_s6UC", "citedby": "2"}, {"bib": {"title": "Abstract B47: Therapeutic KRAS silencing in lung and colon cancer models", "year": "2014"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:r0BpntZqJG4C", "citedby": "2"}, {"bib": {"title": "Clinical relevance of cytokeratin-negative circulating tumor cells.", "year": "2011"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:hMod-77fHWUC", "citedby": "2"}, {"bib": {"title": "True blood: Platelets as a biomarker of ovarian cancer recurrence", "year": "2011"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:UebtZRa9Y70C", "citedby": "2"}, {"bib": {"title": "Diagnostic characteristics of a serum biomarker in patients with positron emission tomography scans", "year": "2010"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:zYLM7Y9cAGgC", "citedby": "2"}, {"bib": {"title": "MA11. 11 STK11/LKB1 Genomic Alterations Are Associated with Inferior Clinical Outcomes with Chemo-Immunotherapy in Non-Squamous NSCLC", "year": "2019"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:NhqRSupF_l8C", "citedby": "1"}, {"bib": {"title": "Immunotherapy combinations emerging in non-small-cell lung cancer", "year": "2018"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:zA6iFVUQeVQC", "citedby": "1"}, {"bib": {"title": "Incorporating pericytes into an endothelial cell bead sprouting assay", "year": "2018"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:ZHo1McVdvXMC", "citedby": "1"}, {"bib": {"title": "Regulation of MYC protein stability by mutant KRAS in pancreatic ductal adenocarcinoma", "year": "2017"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:ldfaerwXgEUC", "citedby": "1"}, {"bib": {"title": "Hypoxia is a master regulator of Drosha-and Dicer-dependent miRNA biogenesis in cancer", "year": "2014"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:IWHjjKOFINEC", "citedby": "1"}, {"bib": {"title": "Silencing the elephant in the room: therapeutic KRAS targeting with siRNA.", "year": "2013"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:WF5omc3nYNoC", "citedby": "1"}, {"bib": {"title": "Fuel on the Fire: Contribution of Thrombocytosis to Ovarian Cancer Resistance to Taxane-Based Chemotherapy", "year": "2012"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:_FxGoFyzp5QC", "citedby": "1"}, {"bib": {"title": "Clinical relevance of miR-200 family members in various cancers", "year": "2012"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:e5wmG9Sq2KIC", "citedby": "1"}, {"bib": {"title": "Integrated analysis of Notch pathway in high grade serous ovarian cancer", "year": "2012"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:YOwf2qJgpHMC", "citedby": "1"}, {"bib": {"title": "Redefining CTCs: Detection of cytokeratin-negative circulating tumor cells (CTCs)", "year": "2011"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:HDshCWvjkbEC", "citedby": "1"}, {"bib": {"title": "Erythropoietin meets a new receptor", "year": "2011"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:-f6ydRqryjwC", "citedby": "1"}, {"bib": {"title": "Value of a serum proteomic signature in the non-invasive evaluation of lung nodules.", "year": "2010"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:KlAtU1dfN6UC", "citedby": "1"}, {"bib": {"title": "A very late stent thrombosis in a patient with diabetes: a call for lifelong dual anti-platelet therapy.", "year": "2009"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:M3NEmzRMIkIC", "citedby": "1"}, {"bib": {"title": "Abstract B32: Silencing of oncogenic KRAS by a mutant-favoring short interfering RNA", "year": "2020"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:KxtntwgDAa4C", "citedby": "0"}, {"bib": {"title": "Methods and compositions using RNA interference for inhibition of KRAS", "year": "2020"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:pyW8ca7W8N0C", "citedby": "0"}, {"bib": {"title": "Histone deacetylase 11 inhibition promotes breast cancer metastasis from lymph nodes", "year": "2019"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:abG-DnoFyZgC", "citedby": "0"}, {"bib": {"title": "Incidence and clinical relevance of non-small cell lung cancer lymph node micro-metastasis detected by staging endobronchial ultrasound-guided transbronchial needle aspiration", "year": "2019"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:b0M2c_1WBrUC", "citedby": "0"}, {"bib": {"title": "Factor XIIIA-expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking", "year": "2019"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:_xSYboBqXhAC", "citedby": "0"}, {"bib": {"title": "High Capacity poly (2-oxazoline) formulation of TLR 7/8 agonist extends survival in a chemo-insensitive, metastatic model of Lung Adenocarcinoma", "year": "2019"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:CHSYGLWDkRkC", "citedby": "0"}, {"bib": {"title": "Therapeutic Silencing of Oncogenic KRAS With a Mutant-Specific Short Interfering RNA: MA27. 06", "year": "2018"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:P5F9QuxV20EC", "citedby": "0"}, {"bib": {"title": "P2. 03-20 Factor XIIIA-Expressing Inflammatory Monocytes Promote Lung Squamous Cancer through Fibrin Cross-Linking", "year": "2018"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:yD5IFk8b50cC", "citedby": "0"}, {"bib": {"title": "P1. 05-01 Incidence and Clinical Relevance of NSCLC Lymph Node Micro-Metastasis Detected by Staging EBUS-TBNA", "year": "2018"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:cFHS6HbyZ2cC", "citedby": "0"}, {"bib": {"title": "MA27. 06 Therapeutic Silencing of Oncogenic KRAS With a Mutant-Specific Short Interfering RNA", "year": "2018"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:dfsIfKJdRG4C", "citedby": "0"}, {"bib": {"title": "Abstract P1-01-03: Preclinical evidence that distant metastases occur via the lymphatic route", "year": "2018"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:HoB7MX3m0LUC", "citedby": "0"}, {"bib": {"title": "A miR-155/TP53 regulatory feedback loop involved in resistance to therapy in lung cancer and leukemia", "year": "2017"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:u_35RYKgDlwC", "citedby": "0"}, {"bib": {"title": "Abstract A47: miR-30c: a TGF beta-regulated miRNA that coordinates vascular-directed fibrinolysis and tumor angiogenesis", "year": "2016"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:NaGl4SEjCO4C", "citedby": "0"}, {"bib": {"title": "Novel Regulators Of Metastases In Lung Squamous Carcinoma", "year": "2016"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:RGFaLdJalmkC", "citedby": "0"}, {"bib": {"title": "Abstract B10: Effects of vascular normalization when combining miR-200b with radiation", "year": "2015"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:TFP_iSt0sucC", "citedby": "0"}, {"bib": {"title": "Abstract C16: Mapping synthetic vulnerabilities in non-small cell lung cancer", "year": "2013"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:M3ejUd6NZC8C", "citedby": "0"}, {"bib": {"title": "Separating the good, the bad, and the ugly: New directions in genomic prediction of outcome in ovarian cancer", "year": "2013"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:MXK_kJrjxJIC", "citedby": "0"}, {"bib": {"title": "Deception of suppression: Unexpected effects of tristetraprolin in ovarian cancer", "year": "2013"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:0EnyYjriUFMC", "citedby": "0"}, {"bib": {"title": "The Eph Family: Not playing nice in uterine cancer", "year": "2013"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:eQOLeE2rZwMC", "citedby": "0"}, {"bib": {"title": "Ten degrees of separation: novel genes affecting outcome in ovarian cancer.", "year": "2013"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:Zph67rFs4hoC", "citedby": "0"}, {"bib": {"title": "Overcoming platinum-resistance in ovarian cancer via targeting basonuclin1 (BNC1).", "year": "2013"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:Se3iqnhoufwC", "citedby": "0"}, {"bib": {"title": "An integrated analysis of the eph/ephrin family: implications in endometrial cancer.", "year": "2013"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:roLk4NBRz8UC", "citedby": "0"}, {"bib": {"title": "Hematogenous metastasis in ovarian cancer: Importance of the ErbB3/NRG axis.", "year": "2013"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:ufrVoPGSRksC", "citedby": "0"}, {"bib": {"title": "Basonuclin1 (BNC1): A novel therapeutic target in ovarian cancer identified through integrative TCGA-based functional genomic analysis", "year": "2012"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:RHpTSmoSYBkC", "citedby": "0"}, {"bib": {"title": "Suicidal tendencies: The promotion of cell death by a prolactin antagonist through autophagy in ovarian cancer", "year": "2012"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:R3hNpaxXUhUC", "citedby": "0"}, {"bib": {"title": "Contribution of malignant thrombocytosis to ovarian cancer proliferation and resistance to chemotherapy-induced-apoptosis through Platelet Derived Growth Factor Receptor-Alpha \u2026", "year": "2012"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:TQgYirikUcIC", "citedby": "0"}, {"bib": {"title": "A novel mechanism of hypoxia mediated cell cycle dysregulation: miR-134 targets CDKN2A", "year": "2012"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:kNdYIx-mwKoC", "citedby": "0"}, {"bib": {"title": "Discovery of an alternate erythropoietin receptor: The Eph connection", "year": "2012"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:hqOjcs7Dif8C", "citedby": "0"}, {"bib": {"title": "Fuel on the Fire: Contribution of Thrombocytosis to Ovarian Cancer Resistance to Taxane-Based Chemotherapy", "year": "2012"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:LkGwnXOMwfcC", "citedby": "0"}, {"bib": {"title": "RNA \u5e72\u6e09\u306e\u81e8\u5e8a\u5fdc\u7528: \u8ab2\u984c\u3068\u4eca\u5f8c\u306e\u65b9\u5411\u6027", "year": "2011"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:8k81kl-MbHgC", "citedby": "0"}, {"bib": {"title": "In Search of a novel EPO receptor: The clinical significance of the Eph connection", "year": "2011"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:mB3voiENLucC", "citedby": "0"}, {"bib": {"title": "Identification and characterization of novel galectin-9 splice variants in endothelial cells", "year": "2011"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:Wp0gIr-vW9MC", "citedby": "0"}, {"bib": {"title": "Board Certification Medical Oncology, 11/2012", "year": "2009"}, "source": "citations", "id_citations": "8Bm3YUwAAAAJ:M05iB0D1s5AC", "citedby": "0"}]}